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Introduction of the Problem 
 
According to the Centers for Disease Control and Prevention (CDC), in 2016, more than 
11.5 million Americans reported misusing prescription opioids in the past year (CDC, 2018a). As 
many as one in four patients receiving long-term opioid therapy in a primary care setting struggle 
with opioid addiction (CDC, 2018b). The need for better screening for patients at high risk for 
abuse is imperative to decrease the number of opioids prescribed to patients with addictive traits. 
In 2017 alone, there were approximately 47,000 deaths related to overdoses, and 36% were 
prescription-related opioids (CDC, 2017). Identifying patients who at high risk for opioid abuse 
before being prescribed such medication can potentially decrease the number of opioids 
prescribed, thus decreasing the number of overdoses yearly. This project aimed to implement the 
use of an opioid abuse risk assessment screening tool at one Midwest primary care clinic, and to 
identify patients at increased risk for prescription drug abuse. Current guidelines recommend 
screening patients before prescribing opioids (CDC, 2017).   
Literature Review 
 
This literature review aimed to evaluate the effectiveness of opioid abuse risk assessment 
tools and identifying those at risk for drug abuse. Methods of implementing risk assessment tools 
in the primary care setting and determining which opioid abuse assessment tools were validated 
in the literature. Themes that emerged from the literature search were clinical relevance of opioid 
abuse, risk factors for opioid misuse among patients, risk factors for primary care providers 
prescribing opioid medications, signs and symptoms of opioid abuse, consequences of 
prescription opioid abuse, validated opioid abuse screening tools, and incentives for primary care 
providers to implement office-based screening.  
The use of recommended monitoring guidelines has been shown to be useful for 
identifying patients at risk of developing opioid or substance abuse dependency (Loheswaran et 
al., 2015). Setnik, Roland, Pixton, and Sommerville (2017) performed an analysis on the 
effectiveness of standardized opioid risk assessment tools. It was found that a standardized risk 
assessment tool should be considered for all patients who are on chronic opioid therapy, thus 
helping to identify patients who may be at risk for or who are engaging in prescription opioid 
misuse, abuse, and diversion (Setnik et al.,2017).  Risk factors include having a present or past 
history of alcohol abuse, tobacco abuse, depression, anxiety, illicit drug use, antisocial 
personality, and childhood adversity (Dela Cruz & Trivedi, 2015). Primary health care providers 
should assess for signs and symptoms of opioid abuse when prescribing opioid medications due 
to the potential for significant adverse effects of opioid misuse. The major adverse consequences 
of opioid misuse include drug tolerance, physical dependence, addiction, and even death. 
 The following validated screening tools can identify patients at an increased risk of 
opioid abuse: The Brief Pain Inventory (BPI), the Screener and Opioid Assessment for Patients 
with Pain-Revised (SOAPP-R), the Opioid Risk Tool (ORT), and the Diagnosis, Intractability, 
Risk, Efficacy (DIRE) (Dela Cruz &Trivedi, 2015). According to a study by Webster and 
Webster (2005), the use of the Opioid Risk Tool (ORT) showed that patients who were at high 
risk of abusing opioids displayed more aberrant behaviors than those who were in the moderate 
to low risk groups.  The ORT’s use demonstrated accuracy and validated those predicted to be at 
high risk and at low risk for opioid-related adverse behaviors. According to Letourneau et al. 
(2019), the use of opioid risk screenings by physicians benefit their patients by helping to 
prevent, identify, and subsequently successfully treat opioid addiction.  
There is significant evidence that the abuse and misuse of opioids is a serious problem. 
The need to have screening protocols in place is important to identify patients who may be at 
high risk of dependency before prescribing opioids. Key topics include risk factors to receiving 
adequate care, the importance of early identification of abuse or misuse and intervention, and 
potential effects on quality of life. In the primary care setting, it has been shown that many 
opioids are prescribed every year with very little screening in place. Education for prescribers is 
important to help understand when to prescribe opioids versus non-opioid and when to taper 
patients currently on opioids. The research available is limited regarding the use of screening 
tools because most providers do not utilize them. Despite providers understanding their utility in 
practice, screening tools are not often used because of the perception that they are time-
consuming. Implementing a short question screening tool is more likely to be utilized in the 
primary care setting and adopted for continued use. 
Project Methods 
The setting for this project was rural family practice clinic in an underserved region of 
southern Illinois. The project’s education, implementation, and staff evaluation component of the 
project took place from June 2020 through November 2020. Providers at the clinic expressed a 
need for a standardized way to identify patients at risk for opioid abuse prior to prescribing 
opioids. The clinic lacked a protocol or current practice for assessing the risk of opioid abuse 
when prescribing opioid medications. The office was amendable to the change and it 
demonstrated stakeholder support for the project to be implemented at rural clinic in Harrisburg, 
Illinois.  
The tool chosen for this project was the Opioid Risk Assessment Tool (ORT). This 
project was found to be exempt from the IRB review board because it is a quality improvement 
project. After obtaining exemption from the Southern Illinois University Edwardsville 
institutional review board, providing education was the first step in implementing this tool. 
Educational in-services were provided to the physicians and clinical staff on how to use and 
evaluate the ORT. The education included topics such as the importance of screening for opioid 
abuse in the primary care setting and the implementing a new opioid abuse risk assessment 
screening tool. Handouts were discussed and provided to the staff then placed in a binder for 
reference. Implementation of the ORT assisted the primary care provider in choosing appropriate 
analgesic treatments for patients.  The screening tool’s implementation was performed by 
clinical staff and administered to any patient who presented with pain or injury that may have 
required a prescription for pain control. The ORT was also used for current patients already 
receiving opioids to assess for potential aberrant behaviors. 
Evaluation 
Analysis of the project data and interpretation of the findings occurred from November 
2020 until January 2021. Data was collected over a period of 4 months. Due to the pandemic and 
a corresponding decrease in routine office visits, the number of ORT’s were less than expected. 
There were 75 total ORTs completed, 40 (46.7%) being female patients, and 35 (42.7%) male. 
The majority (89.3%) of patients were between the ages of 16-45. Despite the limitations due to 
COVID -19, the ORT demonstrated usefulness in practice. The use of this tool after the 
pandemic could have a significant impact in identifying patients who are at risk of dependency.    
According to the data, most of the participants had low risk profiles for opioid abuse or 
may not have disclosed current or past history of risk factors. Based on the ORT scores of the 75 
patients screened, 69.3% of patients (n=52, 55% of females, 85.70% of males) were classified as  
low risk, 25.3% (n=19, 37.5% of females, 11.43% of males) were moderate risk, and 5.3% (n=4, 
7.5% of females, 2.9% of males) were high risk of developing opioid dependency. Female 
patients had overall more positive responses in all risk categories. A past family history of 
alcohol abuse or personal history of alcohol abuse was reported by 17.5% and 10% of females 
respectively compared to only 5.7% and 2.9% of males. Similarly, females had 5% higher 
incidence of family history of illegal and prescription drug use than males. Females reported 
having a 10% history of prescription drug abuse compared to only 2.9% of males. The only 
category in which men reported higher risk was that of use of illegal drugs, 2.9% of men and 
none of the women. The most significant finding was the number of patients who were 
requesting opioid prescriptions for pain had a high rate of some type of mental health diagnosis. 
Personal history of depression was reported by 62.5% of females and 42.9% of males, with 
additional mental health conditions being reported at 25% by women and 11.4% by men.   
Impact on Practice 
The immediate impact at the clinical site was that some patients who may be at risk for 
opioid or substance abuse were identified. According to the feedback from the providers, the 
ORT data was very helpful in deciding on whether to prescribe opioids. In cases where the 
patient was determined to be high or moderate risk, the providers decided to discuss alternate 
treatment plans with these patients with additional education and reasoning discussed with the 
patient as to why the decision not to prescribe opioids was chosen.  
Due to Covid-19, more data would be needed to determine a significant impact on the 
number of opioids prescribed and subsequent decrease in opioid abuse and overdose. Results of 
this project indicate that education on the ORT helped providers to identify patients at risk for 
opioid abuse by using this tool. Once patients are seen in the office for pain-related complaints at 
normal capacity this tool will be better utilized as part of the standard of care in the office.  
Conclusions 
 The findings from the ORT administration demonstrate that the use of an ORT in the 
clinic setting could prevent or decrease opioid misuse by determining which patients may be at 
higher risk. The literature supports that administering these tools can lead to improved detection 
of opioid misuse and those at risk of becoming addicted. With the adoption of the ORT more 
patients can be screened and identified to prompt intervention and prevention of opioid misuse.  
 
